Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PAL who wrote (3232)	12/8/1997 5:23:00 PM
From: Joe E.	Read Replies (1) of 6136

<<Had a chance to watch Peter Johnson on Squawk Box/CNBC this morning. I get the impression that, this guy who is a brilliant researcher in biotech is not a public speaker. His answers were dull and did not exploit the opportunity to present his case.>> I saw him too. It was dull. And today was a really dull day for the CNBC team- they kept complaining about how little news there was. Other comments: the questions were puffballs, and Mr. Johnson was treated respectfully. He looked very pale and washed out in the lights from the San Diego studio, which added to the effect. However I do think that people who saw the report who do not follow Agouron might just look into it as a result of seeing the piece. It was not a negative at all, just not a big positive.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next